 | • レポートコード：GIR-105X02587 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Machinery & Equipment |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、二重特異性抗体治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。二重特異性抗体治療の種類別市場規模（ベアリングFc領域、欠乏Fc領域）、用途別市場規模（骨学、肺、呼吸器疾患、腫瘍学、遺伝子治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・二重特異性抗体治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Creative-biolabs、PharmAbcine、Sorrento Therapeutics、Patheon ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ベアリングFc領域、欠乏Fc領域 ・用途別分析2016年-2026年：骨学、肺、呼吸器疾患、腫瘍学、遺伝子治療 ・二重特異性抗体治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・二重特異性抗体治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・二重特異性抗体治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・二重特異性抗体治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・二重特異性抗体治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Bispecific Antibody Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Bispecific Antibody Therapeutic size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Bispecific Antibody Therapeutic market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Bispecific Antibody Therapeutic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bearing An Fc Region
Lacking An Fc Region
Market segment by Application can be divided into
Osteology
Pulmonary
Respiratory Diseases
Oncology
Gene Therapy
The key market players for global Bispecific Antibody Therapeutic market are listed below:
Creative-biolabs
PharmAbcine
Sorrento Therapeutics
Patheon
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Bispecific Antibody Therapeutic Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bispecific Antibody Therapeutic Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Bearing An Fc Region
1.2.3 Lacking An Fc Region
1.3 Market Analysis by Application
1.3.1 Overview: Global Bispecific Antibody Therapeutic Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Osteology
1.3.3 Pulmonary
1.3.4 Respiratory Diseases
1.3.5 Oncology
1.3.6 Gene Therapy
1.4 Global Bispecific Antibody Therapeutic Market Size & Forecast
1.4.1 Global Bispecific Antibody Therapeutic Sales in Value (2016-2026))
1.4.2 Global Bispecific Antibody Therapeutic Sales in Volume (2016-2026)
1.4.3 Global Bispecific Antibody Therapeutic Price by Type (2016-2026) & (USD/Unit)
1.5 Global Bispecific Antibody Therapeutic Production Capacity Analysis
1.5.1 Global Bispecific Antibody Therapeutic Total Production Capacity (2016-2026)
1.5.2 Global Bispecific Antibody Therapeutic Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bispecific Antibody Therapeutic Market Drivers
1.6.2 Bispecific Antibody Therapeutic Market Restraints
1.6.3 Bispecific Antibody Therapeutic Trends Analysis
2 Manufacturers Profiles
2.1 Creative-biolabs
2.1.1 Creative-biolabs Details
2.1.2 Creative-biolabs Major Business
2.1.3 Creative-biolabs Bispecific Antibody Therapeutic Product and Services
2.1.4 Creative-biolabs Bispecific Antibody Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 PharmAbcine
2.2.1 PharmAbcine Details
2.2.2 PharmAbcine Major Business
2.2.3 PharmAbcine Bispecific Antibody Therapeutic Product and Services
2.2.4 PharmAbcine Bispecific Antibody Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sorrento Therapeutics
2.3.1 Sorrento Therapeutics Details
2.3.2 Sorrento Therapeutics Major Business
2.3.3 Sorrento Therapeutics Bispecific Antibody Therapeutic Product and Services
2.3.4 Sorrento Therapeutics Bispecific Antibody Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Patheon
2.4.1 Patheon Details
2.4.2 Patheon Major Business
2.4.3 Patheon Bispecific Antibody Therapeutic Product and Services
2.4.4 Patheon Bispecific Antibody Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Bispecific Antibody Therapeutic Sales by Manufacturer
3.1 Global Bispecific Antibody Therapeutic Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Bispecific Antibody Therapeutic Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Bispecific Antibody Therapeutic
3.4 Market Concentration Rate
3.4.1 Top 3 Bispecific Antibody Therapeutic Manufacturer Market Share
3.4.2 Top 6 Bispecific Antibody Therapeutic Manufacturer Market Share
3.5 Global Bispecific Antibody Therapeutic Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Bispecific Antibody Therapeutic Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bispecific Antibody Therapeutic Market Size by Region
4.1.1 Global Bispecific Antibody Therapeutic Sales in Volume by Region (2016-2026)
4.1.2 Global Bispecific Antibody Therapeutic Revenue by Region (2016-2026)
4.2 North America Bispecific Antibody Therapeutic Revenue (2016-2026)
4.3 Europe Bispecific Antibody Therapeutic Revenue (2016-2026)
4.4 Asia-Pacific Bispecific Antibody Therapeutic Revenue (2016-2026)
4.5 South America Bispecific Antibody Therapeutic Revenue (2016-2026)
4.6 Middle East and Africa Bispecific Antibody Therapeutic Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Bispecific Antibody Therapeutic Sales in Volume by Type (2016-2026)
5.2 Global Bispecific Antibody Therapeutic Revenue by Type (2016-2026)
5.3 Global Bispecific Antibody Therapeutic Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Bispecific Antibody Therapeutic Sales in Volume by Application (2016-2026)
6.2 Global Bispecific Antibody Therapeutic Revenue by Application (2016-2026)
6.3 Global Bispecific Antibody Therapeutic Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Bispecific Antibody Therapeutic Sales by Type (2016-2026)
7.2 North America Bispecific Antibody Therapeutic Sales by Application (2016-2026)
7.3 North America Bispecific Antibody Therapeutic Market Size by Country
7.3.1 North America Bispecific Antibody Therapeutic Sales in Volume by Country (2016-2026)
7.3.2 North America Bispecific Antibody Therapeutic Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Bispecific Antibody Therapeutic Sales by Type (2016-2026)
8.2 Europe Bispecific Antibody Therapeutic Sales by Application (2016-2026)
8.3 Europe Bispecific Antibody Therapeutic Market Size by Country
8.3.1 Europe Bispecific Antibody Therapeutic Sales in Volume by Country (2016-2026)
8.3.2 Europe Bispecific Antibody Therapeutic Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Bispecific Antibody Therapeutic Sales by Type (2016-2026)
9.2 Asia-Pacific Bispecific Antibody Therapeutic Sales by Application (2016-2026)
9.3 Asia-Pacific Bispecific Antibody Therapeutic Market Size by Region
9.3.1 Asia-Pacific Bispecific Antibody Therapeutic Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Bispecific Antibody Therapeutic Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Bispecific Antibody Therapeutic Sales by Type (2016-2026)
10.2 South America Bispecific Antibody Therapeutic Sales by Application (2016-2026)
10.3 South America Bispecific Antibody Therapeutic Market Size by Country
10.3.1 South America Bispecific Antibody Therapeutic Sales in Volume by Country (2016-2026)
10.3.2 South America Bispecific Antibody Therapeutic Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bispecific Antibody Therapeutic Sales by Type (2016-2026)
11.2 Middle East & Africa Bispecific Antibody Therapeutic Sales by Application (2016-2026)
11.3 Middle East & Africa Bispecific Antibody Therapeutic Market Size by Country
11.3.1 Middle East & Africa Bispecific Antibody Therapeutic Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Bispecific Antibody Therapeutic Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Bispecific Antibody Therapeutic Typical Distributors
12.3 Bispecific Antibody Therapeutic Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Bispecific Antibody Therapeutic Revenue by Type, (USD Million), 2021-2026
Table 2. Global Bispecific Antibody Therapeutic Revenue by Application, (USD Million), 2021-2026
Table 3. Creative-biolabs Basic Information, Manufacturing Base and Competitors
Table 4. Creative-biolabs Major Business
Table 5. Creative-biolabs Bispecific Antibody Therapeutic Product and Services
Table 6. Creative-biolabs Bispecific Antibody Therapeutic Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. PharmAbcine Basic Information, Manufacturing Base and Competitors
Table 8. PharmAbcine Major Business
Table 9. PharmAbcine Bispecific Antibody Therapeutic Product and Services
Table 10. PharmAbcine Bispecific Antibody Therapeutic Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table 12. Sorrento Therapeutics Major Business
Table 13. Sorrento Therapeutics Bispecific Antibody Therapeutic Product and Services
Table 14. Sorrento Therapeutics Bispecific Antibody Therapeutic Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Patheon Basic Information, Manufacturing Base and Competitors
Table 16. Patheon Major Business
Table 17. Patheon Bispecific Antibody Therapeutic Product and Services
Table 18. Patheon Bispecific Antibody Therapeutic Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Bispecific Antibody Therapeutic Sales by Manufacturer (2019-2021e) & (K Units)
Table 20. Global Bispecific Antibody Therapeutic Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Bispecific Antibody Therapeutic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Bispecific Antibody Therapeutic Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Bispecific Antibody Therapeutic Production Site of Key Manufacturer
Table 24. Global Bispecific Antibody Therapeutic Sales by Region (2016-2021e) & (K Units)
Table 25. Global Bispecific Antibody Therapeutic Sales by Region (2021-2026) & (K Units)
Table 26. Global Bispecific Antibody Therapeutic Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Bispecific Antibody Therapeutic Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Bispecific Antibody Therapeutic Sales by Type (2016-2021e) & (K Units)
Table 29. Global Bispecific Antibody Therapeutic Sales by Type (2021-2026) & (K Units)
Table 30. Global Bispecific Antibody Therapeutic Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Bispecific Antibody Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Bispecific Antibody Therapeutic Price by Type (2016-2021e) & (USD/Unit)
Table 33. Global Bispecific Antibody Therapeutic Price by Type (2021-2026) & (USD/Unit)
Table 34. Global Bispecific Antibody Therapeutic Sales by Application (2016-2021e) & (K Units)
Table 35. Global Bispecific Antibody Therapeutic Sales by Application (2021-2026) & (K Units)
Table 36. Global Bispecific Antibody Therapeutic Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Bispecific Antibody Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Bispecific Antibody Therapeutic Price by Application (2016-2021e) & (USD/Unit)
Table 39. Global Bispecific Antibody Therapeutic Price by Application (2021-2026) & (USD/Unit)
Table 40. North America Bispecific Antibody Therapeutic Sales by Country (2016-2021e) & (K Units)
Table 41. North America Bispecific Antibody Therapeutic Sales by Country (2021-2026) & (K Units)
Table 42. North America Bispecific Antibody Therapeutic Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Bispecific Antibody Therapeutic Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Bispecific Antibody Therapeutic Sales by Type (2016-2021e) & (K Units)
Table 45. North America Bispecific Antibody Therapeutic Sales by Type (2021-2026) & (K Units)
Table 46. North America Bispecific Antibody Therapeutic Sales by Application (2016-2021e) & (K Units)
Table 47. North America Bispecific Antibody Therapeutic Sales by Application (2021-2026) & (K Units)
Table 48. Europe Bispecific Antibody Therapeutic Sales by Country (2016-2021e) & (K Units)
Table 49. Europe Bispecific Antibody Therapeutic Sales by Country (2021-2026) & (K Units)
Table 50. Europe Bispecific Antibody Therapeutic Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Bispecific Antibody Therapeutic Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Bispecific Antibody Therapeutic Sales by Type (2016-2021e) & (K Units)
Table 53. Europe Bispecific Antibody Therapeutic Sales by Type (2021-2026) & (K Units)
Table 54. Europe Bispecific Antibody Therapeutic Sales by Application (2016-2021e) & (K Units)
Table 55. Europe Bispecific Antibody Therapeutic Sales by Application (2021-2026) & (K Units)
Table 56. Asia-Pacific Bispecific Antibody Therapeutic Sales by Region (2016-2021e) & (K Units)
Table 57. Asia-Pacific Bispecific Antibody Therapeutic Sales by Region (2021-2026) & (K Units)
Table 58. Asia-Pacific Bispecific Antibody Therapeutic Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Bispecific Antibody Therapeutic Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Bispecific Antibody Therapeutic Sales by Type (2016-2021e) & (K Units)
Table 61. Asia-Pacific Bispecific Antibody Therapeutic Sales by Type (2021-2026) & (K Units)
Table 62. Asia-Pacific Bispecific Antibody Therapeutic Sales by Application (2016-2021e) & (K Units)
Table 63. Asia-Pacific Bispecific Antibody Therapeutic Sales by Application (2021-2026) & (K Units)
Table 64. South America Bispecific Antibody Therapeutic Sales by Country (2016-2021e) & (K Units)
Table 65. South America Bispecific Antibody Therapeutic Sales by Country (2021-2026) & (K Units)
Table 66. South America Bispecific Antibody Therapeutic Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Bispecific Antibody Therapeutic Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Bispecific Antibody Therapeutic Sales by Type (2016-2021e) & (K Units)
Table 69. South America Bispecific Antibody Therapeutic Sales by Type (2021-2026) & (K Units)
Table 70. South America Bispecific Antibody Therapeutic Sales by Application (2016-2021e) & (K Units)
Table 71. South America Bispecific Antibody Therapeutic Sales by Application (2021-2026) & (K Units)
Table 72. Middle East & Africa Bispecific Antibody Therapeutic Sales by Country (2016-2021e) & (K Units)
Table 73. Middle East & Africa Bispecific Antibody Therapeutic Sales by Country (2021-2026) & (K Units)
Table 74. Middle East & Africa Bispecific Antibody Therapeutic Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Bispecific Antibody Therapeutic Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Bispecific Antibody Therapeutic Sales by Type (2016-2021e) & (K Units)
Table 77. Middle East & Africa Bispecific Antibody Therapeutic Sales by Type (2021-2026) & (K Units)
Table 78. Middle East & Africa Bispecific Antibody Therapeutic Sales by Application (2016-2021e) & (K Units)
Table 79. Middle East & Africa Bispecific Antibody Therapeutic Sales by Application (2021-2026) & (K Units)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Bispecific Antibody Therapeutic Typical Distributors
Table 83. Bispecific Antibody Therapeutic Typical Customers
List of Figures
Figure 1. Bispecific Antibody Therapeutic Picture
Figure 2. Global Bispecific Antibody Therapeutic Sales Market Share by Type in 2020
Figure 3. Bearing An Fc Region
Figure 4. Lacking An Fc Region
Figure 5. Global Bispecific Antibody Therapeutic Sales Market Share by Application in 2020
Figure 6. Osteology
Figure 7. Pulmonary
Figure 8. Respiratory Diseases
Figure 9. Oncology
Figure 10. Gene Therapy
Figure 11. Global Bispecific Antibody Therapeutic Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Bispecific Antibody Therapeutic Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Bispecific Antibody Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Bispecific Antibody Therapeutic Sales (2016-2026) & (K Units)
Figure 33. Global Bispecific Antibody Therapeutic Production Capacity (2016-2026) & (K Units)
Figure 34. Global Bispecific Antibody Therapeutic Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Bispecific Antibody Therapeutic Market Drivers
Figure 36. Bispecific Antibody Therapeutic Market Restraints
Figure 37. Bispecific Antibody Therapeutic Market Trends
Figure 38. Global Bispecific Antibody Therapeutic Sales Market Share by Manufacturer in 2020
Figure 39. Global Bispecific Antibody Therapeutic Revenue Market Share by Manufacturer in 2020
Figure 40. Bispecific Antibody Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Bispecific Antibody Therapeutic Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Bispecific Antibody Therapeutic Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Bispecific Antibody Therapeutic Sales Market Share by Region (2016-2026)
Figure 44. Global Bispecific Antibody Therapeutic Revenue Market Share by Region (2016-2026)
Figure 45. North America Bispecific Antibody Therapeutic Revenue (2016-2026) & (USD Million)
Figure 46. Europe Bispecific Antibody Therapeutic Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Bispecific Antibody Therapeutic Revenue (2016-2026) & (USD Million)
Figure 48. South America Bispecific Antibody Therapeutic Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Bispecific Antibody Therapeutic Revenue (2016-2026) & (USD Million)
Figure 50. Global Bispecific Antibody Therapeutic Sales Market Share by Type (2016-2026)
Figure 51. Global Bispecific Antibody Therapeutic Revenue Market Share by Type (2016-2026)
Figure 52. Global Bispecific Antibody Therapeutic Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Bispecific Antibody Therapeutic Sales Market Share by Application (2016-2026)
Figure 54. Global Bispecific Antibody Therapeutic Revenue Market Share by Application (2016-2026)
Figure 55. Global Bispecific Antibody Therapeutic Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Bispecific Antibody Therapeutic Sales Market Share by Country (2016-2026)
Figure 57. North America Bispecific Antibody Therapeutic Revenue Market Share by Country (2016-2026)
Figure 58. North America Bispecific Antibody Therapeutic Sales Market Share by Type (2016-2026)
Figure 59. North America Bispecific Antibody Therapeutic Sales Market Share by Application (2016-2026)
Figure 60. Europe Bispecific Antibody Therapeutic Sales Market Share by Country (2016-2026)
Figure 61. Europe Bispecific Antibody Therapeutic Revenue Market Share by Country (2016-2026)
Figure 62. Europe Bispecific Antibody Therapeutic Sales Market Share by Type (2016-2026)
Figure 63. Europe Bispecific Antibody Therapeutic Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Bispecific Antibody Therapeutic Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Bispecific Antibody Therapeutic Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Bispecific Antibody Therapeutic Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Bispecific Antibody Therapeutic Sales Market Share by Application (2016-2026)
Figure 68. South America Bispecific Antibody Therapeutic Sales Market Share by Country (2016-2026)
Figure 69. South America Bispecific Antibody Therapeutic Revenue Market Share by Country (2016-2026)
Figure 70. South America Bispecific Antibody Therapeutic Sales Market Share by Type (2016-2026)
Figure 71. South America Bispecific Antibody Therapeutic Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Bispecific Antibody Therapeutic Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Bispecific Antibody Therapeutic Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Bispecific Antibody Therapeutic Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Bispecific Antibody Therapeutic Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の癌用二重特異性抗体市場 2021：企業別、地域別、種類・用途別 The Bispecific Antibodies for Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…- 世界の抗体アイソタイピングキット市場 2021：企業別、地域別、種類・用途別 The Antibody Isotyping Kit market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- B4GN4抗体の世界市場2018-2025 In 2018, the global B4GN4 Antibody market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for B4GN4 Antibody. This study researches…
- C1GLT抗体の世界市場2018-2025 In 2018, the global C1GLT Antibody market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for C1GLT Antibody. This study researches…
- デジタル治療機器の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological condition Scope of the Report: This report studies the Digital Therapeutic Devices market status and outlook …